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1. Introduction  
Hypothyroidism is defined as a clinical state resulting from insufficient secretion of thyroid 
hormone from thyroid gland due to some structural or/and functional impairments in 
thyroid hormone production (Kek PC et al., 2003, Dashe JS & Cunningham FG., 2001). 
Hypothyroidism effects all of the organ systems. Main clinical findings are fatigue, 
weakness, dryness and coarseness of the skin, cold intolerance, swelling of the extremities, 
hair loss, lack of concentration and memory,  constipation, weight gain without loss of 
appetite, dyspnea, hoarseness of speech, menorrhagia, paraesthesia, hearing disorders, 
diffuse alopecia, bradycardia, delayed relaxation of tendon reflexes, carpal tunnel syndrome 
and serous cavitary effusions (Kek PC et al., 2003). All of these signs and symptoms recover 
after replacement of thyroid hormone (Larsen PR & Davies TF, 2003, Fatourechi V., 2001).). 
Subclinical hypothyroidism reflects the earliest stage of thyroid dysfunction with subjects 
having normal or decreased fT4, normal fT3 and decreased TSH levels. Since diagnosis 
depends on laboratory values, theoretically, no symptoms or signs are expected but yet 
patients may suffer from somnolence, weakness and fatigue (Kek PC et al., 2003).    
In the English literature there exsists several studies revealing the effect of clinical 
hypothyroidism on respiratory and cardiovascular systems but we were not able to find any 
comparative effect of subclinical hypothyroidism on these systems. In this study we evaluated 
the respiratory function in subclinical hypothyroidism as well as comparing the results with 
clinical hypothyroidism and healthy control groups. Our aim was to determine if respiratory 
function was effected in subclinical hypothyroidism by using simple spirometry. 
2. Materials and methods 
Two hundred and sixty-seven subjects were enrolled in the study. None of the participants 
had a history of smoking, any respiratory illness or any other systemic pathology affecting 
the respiratory system. The patients did not suffer from goitre disturbing  the respiratory 
function. The body mass indices (BMI) of all  of the participants were under 30 kg/m2. 
Following the approval of the local ethics committee written informed consent was obtained 
from all of the participants.  
Serum fT3, fT4 levels were assessed by Chemiluminescent Competitive Enzyme 
Immunoassay method with Immulite 2000 of BIODPC. Serum TSH analysis was performed 
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by Enzyme Chemiluminescent Immunometric Assay method with the same analyser. 
Normal range for TSH was <4.0 uIU/ml, 1.57-4.71 ng/ml for fT3, and 0.8-1.8 ng/ml for fT4 . 
If the patients' serum fT3 level was between 1.57-4.71 ng/ml, fT4 was between 0.8-1.8 ng/ml 
and  TSH level was >4.0 uIU/ml, they were included in the subclinical hypothyroidism 
group. On the other hand, if their serum levels of  fT3 was <1.57 ng/ml, fT4<0.8 ng/ml and 
TSH was >4.0 uIU/ml; they were included in the clinical hypothyroidism group. The 
control group consisted of  subjects having normal fT3, fT4 and TSH values.  
Spirometric analysis was performed with Jaeger Master Scobe (version 4.5). All respiratory 
parameters including FVC, FVC %,  FEV1, FEV1 %,  FEV1/FVC, FEF25-75, FEF25-75 %, PEF, PEF 
% were assessed.  
The mean and standard deviation of parametric values were assessed with Students'-t test 
and ANOVA.  Chi-square test was used when assessing the percentages of the groups and 
Pearson correlation was used to compare the groups.  P<0.05 was considered as significant.  
3. Results 
Among 120 patients enrolled into the study with subclinical hypothroidism,  114 of them 
were women and 6 were men while there were 86 women and 3 male patients with clinical 
hypothyroidism. Control group consisted of 51 women and 9 men. The mean age of the 
patients was 43±13 years and 41±13 years with subclinical hypothyroidism and clinical 
hypothyroidism, respectively. The mean age was 41±12 years in the control group. There 










Age/years 43.68±13.31 41.97±13.22 41.45±11.98 
Gender F 114 84 51 
M 6 3 9 
Table 1. Demographic features of the participants  
Serum fT3, fT4  and TSH values and spirometric parameters of the groups are shown at Table 2 
and 3, respectively. Spirometric values were the lowest in the clinical hypothyroidism group 










fT3 (ng/ml) 2,82±0,76 1,65±0,85 3,12±1.01 
fT4(ng/dl) 1,06±0,16 0,52±0,22 1,17±0,23 
TSH(uIU/m) 10,19±6,22 74,17±140,78 1,60±1,07 
Table 2. Thyroid function values of the participants 
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The comparison between clinical hypothyroidism and control group demonstrated that all 
of the spirometric parameters were higher in control group;but only  the differences among 
FVC, FVC %, FEV1, FEF 25-75  reached statistical significance   
 (p<0.05); the others were not statistically significant.  
According to the comparison between subclinical hypothyroidism and control group, 
spirometric parameters were higher in the control group and lower in patients with 
subclinical hypothyroidism and there was a statistical significant difference regarding FVC, 
FVC %, FEV1 and FEF25-75 (p<0.05).   
Statistically significant positive correlation was found  between FT4  and FVC % in patients 










FVC(ml) 3284±574* 3218±767* 3565±806 
FVC % 109±18* 105±19* 115±15 
FEV1(ml) 2661±529* 2614±623* 2866±706 
FEV1 % 103±16 100±21 106±14 
FEV1/FVC 80±9 80±7 78±6 
FEF25-75(ml) 4716±1415* 4534±1470* 9034±13162 
FEF25-75 % 81±22 79±26 81±20 
PEF(ml) 4966±1413 4940±1337 5374±1932 
PEF % 77±20 77±21 80±21 
Table 3. Spirometry parameters of the participants 
There was a positive correlation between fT3 and FEF25-75 (r=0.484, p=0.0001), FEF25-75 % 
(r=0.490, p=0.0001), PEF (r=0.419, p=0.0001) and PEF% (r=0.432, p=0.0001) in the clinical 
hypothyroidism group. There was also a positive correlation between fT4 and FEF25-75 
(r=0.211, p=0.05), FVC (r=0.251, p=0.019) and FVC% (r=0.248, p=0.021). On the other hand, 
there was a negative correlation between TSH and FVC%  (r= -0.249, p=0.02). 
4. Conclusion 
Hypothyroidism and subclinical hypothyroidism is a clinical disorder  occuring frequently 
in community. Literature research reveals many studies regarding the effects of clinical 
hypothyroidism on respiratory and cardiovascular systems. But there exists no study 
concerning the effect of subclinical hypothyroidism on respiratory system nor there exists 
any study comparing healthy subjects to clinical hypothyroid patients in terms of 
respiratory function tests. Therefore we aimed to assess the respiratory function of patients 
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with subclinical hypothyroidism in comparison with clinical hypothyroidism and healthy 
subjects. 
The incidence of primary hypothyroidism is 2% in women and 0.2% in men. 
Hypothyroidism effects all of the organ systems (Kek PC et al., 2003, Larsen PR & Davies 
TF, 2003). The clinical presentation of thyroid hormone deficiency alters from one person to 
another depending on the duration, cause and the degree of deficiency. The decrease in both 
expiratory and inspiratory muscle strength (Siafakas NM et al., 1992), alveolar 
hypoventilation due to depression of hypoxic and hypercapnoeic ventilatory drives (Kahaly 
GJ, 2000) and decrease in maximal breathing and diffusing capacity (Zwillich CW et al., 
1975) are evident in patients with hypothyroidism. These impairments are reversible with 
hormone replacement therapy. Respiratory infections are more common than healthy 
people (Harrison RN & Tattersfield AE., 1984, Krishnan R et al., 1984). Obstructive sleep 
apnea syndrome is common in severe hypothyroidism but it is reversible with restoration of 
a euthyroid state (Larsen PR & Davies TF, 2003). The prominent features like somnolence, 
apathy and lethargy may also recover with replacement therapy (Krishnan R et al., 1984, 
Jameson JL & Weetman AP, 2001). Muscle strength measurement and sleep investigation is 
not routine analysis in these patients, so simple spirometric evaluation is preferred. Thus, 
we used only spirometric measurements in our study since this method is easier, more 
available and cheaper than other respiratory function tests.  
Siafakas et al. found a significant decrease in the strength of inspiratory and expiratory 
muscles in patients with clinical hypothyroidism. In the mentioned study, vital capacity 
(VC), forced vital capacity (FVC), forced vital capacity one second (FEV1), FEV1/FVC were 
significantly lower in patients with clinical hypothyroidism compared to healtly controls. In 
our study, the patients with clinical hypothyroidism had significantly lower spirometric 
parameters such as vital capacity (VC), forced vital capacity (FVC), forced vital capacity in 
one second (FEV1), FEV1/FVC, peak expiratory flow (PEF) and forced expiratory flow 25-75 
(FEF 25-75) than control group. 
Subclinical hypothyroidism reflects the earliest stage of thyroid dysfunction. Chronical 
autoimmune thyroiditis, subacute thyroiditis, thyroidectomy, radioactive iodine treatment, 
insufficient thyroid hormone replacement therapy may be the cause of  subclinical 
hypothyroidism. The rate of progression to clinical hypothyroidism from subclinical 
hypothyroidism is about  7,8 %-17,8 %. Initiating therapy doesn’t change the natural course 
of the illness, but it prevents the progression of clinical hypothyroidism (Biondi B et al., 
2002, Surks MI & Ocampo E., 1996). 
Subclinical hypothyroidism is a common phenomenon seen more often in women with 
increasing age. The prevalance in women is 6-8 % and 3 % in men (Kek PC et al., 2003, 
Surks MI & Ocampo E., 2004). In our study 114 female and  6 male patients had 
subclinical hypothyroidism. Theoretically no symptoms or findings are expected in 
subclinical hypothyroidism. On the contrary, almost all of our patients suffered from at 
least one or more of the  symptoms like fatigue, weakness and somnolence. This situation 
revealed that clinical findings also associated to spirometric abnormalities. Fatigue is 
observed in subclinical hypothyroidism because of muscle dysfunction. Diagnosis 
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depends on laboratory evaluation. (Kahaly GJ, 2000, Biondi B et al., 2002, Biondi B et al., 
2002).   
The effect of subclinical hypothyroidism on several organ systems are well known, whereas 
the effect on respiratory system is not fully understood (Col NF et al., 2004, Beyer IW et al., 
1998). The study we designed led us to the conclusion that the measurements of spirometric 
variables are higher in subclinical hypothyroidism than in clinical hypothyroidism but 
lower than healthy subjects reaching statistical significance.  
In conclusion it is possible to claim that respiratory system is effected in subclinical 
hypothyroidism. Since subclinical hypothyroidism is common in general population, the 
patients at high risk who had clinical signs and symptoms may be screened with simple 
spirometry. 
5. References 
Beyer IW, Karmali R & Demester MR. (1998). Muscle dysfunction in subclinical 
hypothyroidism. J Clin Endocrinol Metab, May; 83, 50, 1823.  
Biondi B, Palmieri EA & Lombardi G. (2002). Effects of subclinical thyroid dysfunction on 
the heart. Ann Intern Med, Dec 3, 137, 11, 904-914. 
Biondi B, Palmieri FA & Lombardi G. (2002). Subclinical hypothyroidism and cardiac 
function. Thyroid, Jun, 12, 6, 505-510.  
Col NF, Sarks MI & Daniels GH. (2004). Subclinical thyroid disease: Clinical applications. 
JAMA, Apr 7, 291, 13, 1562. 
Dashe JS & Cunningham FG. (2001). Subclinical hypothyroidism. N Engl J Med, Dec 20, 345, 
25, 1855.  
Fatourechi V. (2001). Subclinical thyroid disease. Mayo Clin Proc, Apr, 76, 4, 413-417.  
Harrison R.N & Tattersfield A.E. (1984). Airway response to inhaled salbutamol in 
hyperthyroid and hypothyroid patients before and after treatment. Thoraks, 39, 34-39. 
Jameson JL, Weetman AP. (2001). Diseases of thyroid gland, In: Harrison’s Internal Medicine, 
Braunwald E, Fauci AJ, Kasper DL, Hauser SL, Longo DL, Jameson JL, 2060-2084, 
15th ed, New York: McGraw-Hill. 
Kahaly GJ(2000) Cardiovascular and atherogenic aspects of subclinical hypothyroidism, 
Thyroid,Aug,10,8,665-679. 
Kek PC, Ho SC& Khoo DH. (2003). Subclinical thyroid disease. Singapore Med J, 44, 11 595-
600. 
Krishnan R, Peter HA & Sarkis SD. (1984). Obstructive Sleep Apnea in Hypothyroidism. 
Annuals of Internal Medicine, 101, 491-494. 
Larsen PR & Davies TF. (2003). Hypothyroidsm and thyroiditis, In: Williams Textbook of 
Endocrinology, Larsen PR, Kronenberg HM, Melmed S, Polonsky KS, 423-456, 10th  
ed. Saunders. 
Siafakas NM, Salesiotou V& Filaditaki V. (1992) Respiratory muscle strength in 
hypothyroidism. Chest,J ul, 102,1, 189-194. 
Surks MI & Ocampo E. (1996). Subclinical thyroid disaese. Am J Med. Feb, 100, 2, 217-223. 
www.intechopen.com
 
Hypothyroidism – Influences and Treatments 
 
334 
Surks MI, Ortiz E & Danniels GH. (2004). Subclinical thyroid disease: Scientific review and 
guidelines for diagnosis and management. JAMA, Jan 14, 291, 2, 228-238. 
Zwillich CW, Pierson  PJ & Hofeldt FD. (1975). Ventilatory control in myxedema and 
hypothyroidism. N Eng J Med, Mar, 27, 292, 13, 662-665.  
www.intechopen.com
Hypothyroidism - Influences and Treatments
Edited by Dr. Drahomira Springer
ISBN 978-953-51-0021-8
Hard cover, 348 pages
Publisher InTech
Published online 08, February, 2012
Published in print edition February, 2012
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
Hypothyroidism is the most common thyroid disorder and it is significantly more frequent than presented -
millions of people suffer from this disease without knowing it. People with this condition will have symptoms
associated with slow metabolism. Estimates of subclinical hypothyroidism range between 3 to 8 %, increasing
with age, whereas it more likely affects women than men. About 10% of women may have some degree of
thyroid hormone deficiency. Hypothyroidism may affect lipid metabolism, neurological diseases or other clinical
conditions. The book includes studies on advancements in diagnosis, regulation and replacement therapy,
thyroid ultrasonography and radioiodine therapy for hypothyroidism. "Hypothyroidism - Influences and
Treatments" contains many important specifications, results of scientific studies and innovations for endocrine
practice.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Gulfidan Cakmak (2012). Spirometry in Patients with Clinical and Subclinical Hypothyroidism, Hypothyroidism -
Influences and Treatments, Dr. Drahomira Springer (Ed.), ISBN: 978-953-51-0021-8, InTech, Available from:
http://www.intechopen.com/books/hypothyroidism-influences-and-treatments/spirometry-in-patients-with-
clinical-and-subclinical-hypothyroidism
© 2012 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
